Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial

Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial

Bibliographic Details
Main Authors: Erwann P. Loret, Albert Darque, Elvenn A. Loret, Corinne Nicolino-Brunet, Sophie Morange, Elisabeth Castagnier, Josiane Casanova, Christine Caloustian, Charléric Bornet, Julie Coussirou, Jihen Bousseta, Bertrand Dussol, Isabelle Ravaux
Format: Article
Language:English
Published: Elsevier 2016-05-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020311857

Internet

http://www.sciencedirect.com/science/article/pii/S2055664020311857

Similar Items